Literature DB >> 18550768

Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum.

Paola Bonsi1, Giuseppina Martella, Dario Cuomo, Paola Platania, Giuseppe Sciamanna, Giorgio Bernardi, Jürgen Wess, Antonio Pisani.   

Abstract

Muscarinic autoreceptors regulate cholinergic tone in the striatum. We investigated the functional consequences of genetic deletion of striatal muscarinic autoreceptors by means of electrophysiological recordings from either medium spiny neurons (MSNs) or cholinergic interneurons (ChIs) in slices from single M(4) or double M(2)/M(4) muscarinic acetylcholine receptor (mAChR) knock-out (-/-) mice. In control ChIs, the muscarinic agonist oxotremorine (300 nM) produced a self-inhibitory outward current that was mostly reduced in M(4)(-/-) and abolished in M(2)/M(4)(-/-) mice, suggesting an involvement of both M(2) and M(4) autoreceptors. In MSNs from both M(4)(-/-) and M(2)/M(4)(-/-) mice, muscarine caused a membrane depolarization that was prevented by the M(1) receptor-preferring antagonist pirenzepine (100 nM), suggesting that M(1) receptor function was unaltered. Acetylcholine has been involved in striatal long-term potentiation (LTP) or long-term depression (LTD) induction. Loss of muscarinic autoreceptor function is predicted to affect synaptic plasticity by modifying striatal cholinergic tone. Indeed, high-frequency stimulation of glutamatergic afferents failed to induce LTD in MSNs from both M(4)(-/-) and M(2)/M(4)(-/-) mice, as well as in wild-type mice pretreated with the M(2)/M(4) antagonist AF-DX384 (11-[[2-[(diethylamino)methyl]-1-piperidinyl]acetyl]-5,1 1-dihydro-6H-pyrido[2,3b][1,4] benzodiazepin-6-one). Interestingly, LTD could be restored by either pirenzepine (100 nM) or hemicholinium-3 (10 microM), a depletor of endogenous ACh. Conversely, LTP induction did not show any difference among the three mouse strains and was prevented by pirenzepine. These results demonstrate that M(2)/M(4) muscarinic autoreceptors regulate ACh release from striatal ChIs. As a consequence, endogenous ACh drives the polarity of bidirectional synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550768      PMCID: PMC3849426          DOI: 10.1523/JNEUROSCI.1678-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  33 in total

1.  Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons.

Authors:  Z Yan; J Flores-Hernandez; D J Surmeier
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Spontaneous activity of neostriatal cholinergic interneurons in vitro.

Authors:  B D Bennett; C J Wilson
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

3.  Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice.

Authors:  Weilie Zhang; Anthony S Basile; Jesus Gomeza; Laura A Volpicelli; Allan I Levey; Jürgen Wess
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

4.  Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice.

Authors:  J Gomeza; L Zhang; E Kostenis; C C Felder; F P Bymaster; J Brodkin; H Shannon; B Xia; A Duttaroy; C X Deng; J Wess
Journal:  Life Sci       Date:  2001-04-27       Impact factor: 5.037

5.  Long-term Potentiation in the Striatum is Unmasked by Removing the Voltage-dependent Magnesium Block of NMDA Receptor Channels.

Authors:  P. Calabresi; A. Pisani; N. B. Mercuri; G. Bernardi
Journal:  Eur J Neurosci       Date:  1992       Impact factor: 3.386

6.  Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons.

Authors:  Zhongfeng Wang; Li Kai; Michelle Day; Jennifer Ronesi; Henry H Yin; Jun Ding; Tatiana Tkatch; David M Lovinger; D James Surmeier
Journal:  Neuron       Date:  2006-05-04       Impact factor: 17.173

7.  Muscarinic (m2/m4) receptors reduce N- and P-type Ca2+ currents in rat neostriatal cholinergic interneurons through a fast, membrane-delimited, G-protein pathway.

Authors:  Z Yan; D J Surmeier
Journal:  J Neurosci       Date:  1996-04-15       Impact factor: 6.167

Review 8.  Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development.

Authors:  Jürgen Wess; Richard M Eglen; Dinesh Gautam
Journal:  Nat Rev Drug Discov       Date:  2007-09       Impact factor: 84.694

9.  Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice.

Authors:  E T Tzavara; F P Bymaster; C C Felder; M Wade; J Gomeza; J Wess; D L McKinzie; G G Nomikos
Journal:  Mol Psychiatry       Date:  2003-07       Impact factor: 15.992

10.  Short- and long-term synaptic depression in rat neostriatum.

Authors:  D M Lovinger; E C Tyler; A Merritt
Journal:  J Neurophysiol       Date:  1993-11       Impact factor: 2.714

View more
  36 in total

1.  Effects of dopamine D1-like and D2-like antagonists on cocaine discrimination in muscarinic receptor knockout mice.

Authors:  Morgane Thomsen; Simon Barak Caine
Journal:  Eur J Pharmacol       Date:  2016-02-11       Impact factor: 4.432

2.  Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice.

Authors:  Yunmin Ding; Lisa Won; Jonathan P Britt; Sean Austin O Lim; Daniel S McGehee; Un Jung Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

Review 3.  Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.

Authors:  Anja Cerovecki; Richard Musil; Ansgar Klimke; Florian Seemüller; Ekkehard Haen; Rebecca Schennach; Kai-Uwe Kühn; Hans-Peter Volz; Michael Riedel
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

4.  M1 muscarinic activation induces long-lasting increase in intrinsic excitability of striatal projection neurons.

Authors:  Xiaohui Lv; Jonathan W Dickerson; Jerri M Rook; Craig W Lindsley; P Jeffrey Conn; Zixiu Xiang
Journal:  Neuropharmacology       Date:  2017-03-20       Impact factor: 5.250

5.  Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M1, M2, and M4 receptor knockout mice.

Authors:  Lauren Joseph; Morgane Thomsen
Journal:  Behav Brain Res       Date:  2017-04-22       Impact factor: 3.332

Review 6.  Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.

Authors:  Samuel S Pappas; Daniel K Leventhal; Roger L Albin; William T Dauer
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

Review 7.  Modeling intracellular signaling underlying striatal function in health and disease.

Authors:  Anu G Nair; Omar Gutierrez-Arenas; Olivia Eriksson; Alexandra Jauhiainen; Kim T Blackwell; Jeanette H Kotaleski
Journal:  Prog Mol Biol Transl Sci       Date:  2014       Impact factor: 3.622

Review 8.  Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Authors:  Maryka Quik; James T Boyd; Tanuja Bordia; Xiomara Perez
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

9.  Modulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in mice.

Authors:  Morgane Thomsen; Jürgen Wess; Brian S Fulton; Anders Fink-Jensen; S Barak Caine
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

10.  Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia.

Authors:  Anthony M Downs; Xueliang Fan; Christine Donsante; H A Jinnah; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2019-01-30       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.